Inside the guide
The Peptide Industry Business Blueprint
The September 2026 foundation draft is in editorial preparation. This is its planned structure — the final edition may change before release.
- 01The market in one page
- 02Peptide science without the noise
- 03The four lanes
- 04The 2026 regulatory reset
- 05503A, 503B and GLP-1
- 06RUO: what it is and is not
- 07Human research, IRBs and PepMD
- 08Manufacturing, API and supplier diligence
- 09Quality, COAs and testing
- 10Lyophilization, formulation and logistics
- 11The healthcare delivery stack
- 12Diagnostics, telehealth and pharmacy
- 13Marketing and claims
- 14Business models and economics
- 15The 90-day launch framework
- 16Where the industry is headed
- 17Decision checklists
- 18Sources and further reading